QBR111141

• Research type

  Research Study

• Full title

  AN EXPLORATORY, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE PHARMACOKINETICS OF SINGLE INTRAVENOUS AND ORAL MICRO DOSES OF PF-06273588 IN HEALTHY MALE SUBJECTS

• IRAS ID

  82284

• Sponsor organisation

  Quotient Clinical Ltd

• Eudract number

  2011-001681-18

• Research summary

  The purpose of the study is to look at how PF-06273588, (the study drug) is taken up by the body when given by mouth and by injection.The compound PF-06273588 is a new experimental drug being developed by Pfizer for the potential treatment of HIV/AIDS. As this compound is a new experimental drug and this study is in healthy volunteers, the drug will not be available after the completion of the study. This is the first time this drug will be given to humans.

• REC name

  Scotland A REC

• REC reference

  11/IE/0090

• Date of REC Opinion

  4 Jul 2011

• REC opinion

  Further Information Favourable Opinion